Loading…
Fresenius Medical Care AG is projected to rise to $27.32 by 2027, a +27% move from its current price of $21.56. FMS is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $21.21 | $21.56 | $21.93 | +0.02% |
| May 30 | $21.06 | $21.57 | $22.08 | +0.03% |
| May 31 | $20.95 | $21.57 | $22.21 | +0.05% |
| Jun 1 | $20.86 | $21.57 | $22.31 | +0.07% |
| Jun 2 | $20.78 | $21.58 | $22.40 | +0.08% |
| Jun 3 | $20.71 | $21.58 | $22.49 | +0.10% |
| Jun 4 | $20.65 | $21.58 | $22.56 | +0.11% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $20.65 | $21.58 | $22.56 | +0.11% |
| Week 2 | $20.30 | $21.61 | $23.01 | +0.23% |
| Week 3 | $20.03 | $21.63 | $23.36 | +0.34% |
| Week 4 | $19.82 | $21.66 | $23.67 | +0.46% |
| Week 5 | $19.64 | $21.68 | $23.94 | +0.57% |
| Week 6 | $19.47 | $21.71 | $24.20 | +0.69% |
| Week 7 | $19.33 | $21.73 | $24.44 | +0.80% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics, materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient’s residence, and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.
The company operates through Care Delivery and Care Enablement segments. It also develops, manufactures, and distributes various health care products, including hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, systems for water treatment, and acute cardiopulmonary and apheresis products.
In addition, the company develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular specialty, ambulatory surgery center, physician nephrology practice management, pharmacy and other services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics, as well as through local sales forces, independent distributors, dealers, and sales agents. The company was incorporated in 1996 and is headquartered in Bad Homburg, Germany.
Fresenius Medical Care AG (FMS) is a healthcare stock currently trading at $21.64. It has a market capitalization of $11.62B and is ranked 834 by market cap. The stock shows a BULLISH near-term sentiment, with RSI (14) at 50, and technicals including SMA50 of $22.41 and SMA200 of $23.88.
A defined near-term support sits at $20.19 while resistance is at $23.72. The 30-day price range spans from $19.24 to $24.34, and the annualized volatility stands around 30%. The year-by-year forecast suggests a rising price trajectory with bullish momentum into the late 2020s and beyond, illustrated by growing average prices and ROIs across years.
A major floor 14.2% below — a decisive break under it would weaken the trend.
The nearest floor, 6.4% below — buyers have tended to step in here.
The nearest ceiling, 8.6% above — a clean break opens room to run.
A major ceiling 15.7% above — clearing it would confirm fresh momentum.
Key FMS support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of FMS market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $21.90 | Sell | $21.76 | Sell |
| MA 10 | $21.83 | Sell | $21.84 | Sell |
| MA 20 | $21.85 | Sell | $21.97 | Sell |
| MA 50 | $22.36 | Sell | $22.34 | Sell |
| MA 100 | $22.75 | Sell | $22.83 | Sell |
| MA 200 | $23.86 | Sell | $23.45 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 44.47 | Neutral |
| Stoch RSI (14) | 18.07 | Buy |
| CCI (20) | -41.60 | Neutral |
| Williams %R (14) | -84.68 | Info |
| MACD (12,26,9) | 0.01 | Buy |
| ROC (12) | -2.13 | Sell |
| Bollinger %B (20,2) | 0.37 | Neutral |
| Stochastic %K (14) | 15.32 | Buy |
| TRIX (15) | -0.15 | Sell |
| Awesome (5,34) | -0.45 | Sell |
| Ultimate (7,14,28) | 50.25 | Neutral |
| Momentum (10) | -0.68 | Sell |
| Aroon Osc (25) | -40.00 | Sell |
| Hull MA (9) | 21.69 | Sell |
| ADX (14) | 10.05 | Neutral |
| ATR (14) | 0.36 | Info |
The 30-day technical picture is bullish, with RSI(14) at 50 and a convergence of price action around the current level. The SMA50 is $22.41 and the SMA200 is $23.88, providing a framework for near-term momentum and potential drift toward the resistance level noted at $23.72. This context sits against a current price of $21.64, with a 30-day range between $19.24 and $24.34.
Overall near-term sentiment aligns with upside potential, supported by the moving averages and the defined support at $20.19 and resistance at $23.72.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $20.19 | $21.56 | $29.57 | 0% | Neutral | |
| $22.32 | $27.32 | $35.00 | +27% | Bullish | |
| $26.70 | $33.28 | $43.76 | +54% | Bullish | |
| $32.09 | $40.61 | $54.50 | +88% | Bullish | |
| $32.71 | $41.94 | $57.28 | +95% | Bullish | |
| $34.47 | $44.73 | $62.05 | +107% | Bullish | |
| $38.31 | $50.27 | $70.71 | +133% | Bullish | |
| $39.86 | $52.85 | $75.29 | +145% | Bullish | |
| $46.97 | $62.90 | $90.67 | +192% | Bullish | |
| $53.98 | $72.96 | $106.33 | +238% | Bullish | |
| $70.51 | $99.39 | $151.75 | +361% | Bullish | |
| $145.68 | $220.18 | $360.28 | +921% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $20.19 | $21.56 | $25.27 | +0.00% |
| June 2026 | $18.52 | $21.60 | $25.69 | +0.19% |
| July 2026 | $18.65 | $21.88 | $26.27 | +1.31% |
| August 2026 | $19.42 | $22.89 | $27.67 | +4.59% |
| September 2026 | $19.75 | $23.36 | $28.41 | +2.06% |
| October 2026 | $19.52 | $23.17 | $28.34 | -0.78% |
| November 2026 | $19.72 | $23.48 | $28.85 | +1.31% |
| December 2026 | $20.07 | $23.96 | $29.57 | +2.05% |
Click any year to see its month-by-month FMS forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect FMS to range from $20.19 to $29.57 through 2026. The $21.56 average target implies a 0% move from current prices. A consolidation phase looks the most probable path here.
The FMS price prediction for 2027 points to an average of $27.32 (low $22.32, high $35.00) — a potential gain of +27% on today's $21.56. Momentum favours further upside here.
In 2028, FMS is projected to trade between $26.70 and $43.76, averaging $33.28 — a potential gain of +54% from today's $21.56. That is up +22% on the projected 2027 average. Buyers look set to stay in control over this stretch.
Fresenius Medical Care AG's 2029 outlook centres on $40.61, within a $32.09 to $54.50 range. That is up +22% on the projected 2028 average. That marks a +88% change versus current levels. Momentum favours further upside here.
By 2030, FMS could reach as high as $57.28, with a base case around $41.94 and support toward $32.71 — roughly +95% from $21.56. Buyers look set to stay in control over this stretch.
Expect FMS to range from $34.47 to $62.05 through 2031. The $44.73 average target implies a +107% move from current prices. That is up +7% on the projected 2030 average. Momentum favours further upside here.
The FMS price prediction for 2032 points to an average of $50.27 (low $38.31, high $70.71) — a potential gain of +133% on today's $21.56. Buyers look set to stay in control over this stretch.
In 2033, FMS is projected to trade between $39.86 and $75.29, averaging $52.85 — a potential gain of +145% from today's $21.56. That is up +5% on the projected 2032 average. Momentum favours further upside here.
Fresenius Medical Care AG's 2034 outlook centres on $62.90, within a $46.97 to $90.67 range. That is up +19% on the projected 2033 average. That marks a +192% change versus current levels. Buyers look set to stay in control over this stretch.
By 2035, FMS could reach as high as $106.33, with a base case around $72.96 and support toward $53.98 — roughly +238% from $21.56. Momentum favours further upside here.
Expect FMS to range from $70.51 to $151.75 through 2040. The $99.39 average target implies a +361% move from current prices. That is up +36% on the projected 2035 average. Buyers look set to stay in control over this stretch.
The FMS price prediction for 2050 points to an average of $220.18 (low $145.68, high $360.28) — a potential gain of +921% on today's $21.56. Momentum favours further upside here.
Investing $1,000 in FMS today (≈ 46.382189 FMS) could be worth
$10,212.61
+$9,212.61 (+921%) by 2050 · US Dollar
Based on the average projected FMS price of $220.18 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in FMSwould be worth at today's price.
$1,000 invested in FMS on May 27, 2025 (≈ 33.9098 FMS) would be worth
$731.1
-$268.9 (-26.9%) today · 0.73× · US Dollar
Based on a FMS entry price of $29.49 vs. today's $21.56.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $22.2 | $971.17 | -2.9% |
| 1 month ago | $22.62 | $953.14 | -4.7% |
| 3 months ago | $23.41 | $920.97 | -7.9% |
| 6 months ago | $23.92 | $901.34 | -9.9% |
| 1 year ago | $29.49 | $731.1 | -26.9% |
| All time (5.0y) ago | $39.91 | $540.22 | -46.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our FMS forecast.
Our base-case forecast reaches $43.00 around 2031.
Implied market cap at $43.00: $23.1B
Longer-horizon forecasts show a path of appreciable gains. The 2026 forecast lists an average price of $21.64 with neutral sentiment and a min of $20.19 and a max of $29.57, resulting in an ROI of 0. By 2027 the average rises to $27.10 with a bullish sentiment and a max of $34.74, implying an ROI of 25.2.
The trajectory continues with 2028 at $33.09 (ROI 52.9) and 2029 at $40.05 (ROI 85.1), culminating in 2030 at $41.02 (ROI 89.6) and 2031 at $43.88 (ROI 102.8).
Beyond 2031, the forecast shows further strength: 2032 average $49.11 (ROI 126.9), 2033 average $51.17 (ROI 136.5), 2034 average $61.00 (ROI 181.9), 2035 average $70.55 (ROI 226), 2040 average $95.77 (ROI 342.6), and 2050 average $208.54 (ROI 863.7). All of these come with bullish sentiment. These figures are estimates and not guarantees, and actual results can differ due to market conditions and other risks.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $41.02, with a min of $31.99 and a max of $56.04, and an ROI of 89.6%. The sentiment is BULLISH.
Forecasts show a shift from Neutral in 2026 (avg $21.64, min $20.19, max $29.57, ROI 0) to Bullish in 2027 (avg $27.10, max $34.74, ROI 25.2) and continued upside through 2031–2050, with higher average prices and ROIs (e.g., 2031 avg $43.88, ROI 102.8; 2032 avg $49.11, ROI 126.9; 2040 avg $95.77, ROI 342.6; 2050 avg $208.54, ROI 863.7). These are estimates and not guarantees.
Yes. The forecast max price reaches $60.88 in 2031, with higher maxes in subsequent years (e.g., $69.09 in 2032, $72.92 in 2033, $87.95 in 2034, and $102.84 in 2035). The sentiment remains BULLISH across these years.
Current price: $21.64. Market cap: $11.62B.
The 30-day range is $19.24 to $24.34.
Fresenius Medical Care AG Community Discussion
0Share your Fresenius Medical Care AG price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.